Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.
Identifieur interne : 003241 ( PubMed/Curation ); précédent : 003240; suivant : 003242Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.
Auteurs : L. Alemany [Espagne] ; M. Saunier [Espagne] ; L. Tinoco [Équateur] ; B. Quir S [Espagne] ; I. Alvarado-Cabrero [Mexique] ; M. Alejo [Espagne] ; E A Joura [Autriche] ; P. Maldonado [Brésil] ; J. Klaustermeier [Espagne] ; J. Salmer N [Mexique] ; C. Bergeron [France] ; K U Petry [Allemagne] ; N. Guimerà [Pays-Bas] ; O. Clavero [Espagne] ; R. Murillo [Colombie] ; C. Clavel [France] ; V. Wain [Australie] ; D T Geraets [Pays-Bas] ; R. Jach [Pologne] ; P. Cross [Royaume-Uni] ; C. Carrilho [Mozambique] ; C. Molina [Chili] ; H R Shin [Corée du Sud] ; V. Mandys [République tchèque] ; A M Nowakowski [Pologne] ; A. Vidal [Espagne] ; L. Lombardi [Guatemala] ; H. Kitchener [Royaume-Uni] ; A R Sica [Uruguay] ; C. Maga A-Le N [Mexique] ; M. Pawlita [Allemagne] ; W. Quint [Pays-Bas] ; I G Bravo [Espagne] ; N. Mu Oz [Colombie] ; S. De Sanjosé [Espagne] ; F X Bosch [Espagne]Source :
- European journal of cancer (Oxford, England : 1990) [ 1879-0852 ] ; 2014.
Descripteurs français
- KwdFr :
- ADN viral (analyse), Adulte d'âge moyen, Analyse de régression, Carcinome épidermoïde (), Carcinome épidermoïde (virologie), Carcinome épidermoïde (épidémiologie), Coopération internationale, Femelle, Humains, Infections à papillomavirus (), Infections à papillomavirus (virologie), Infections à papillomavirus (épidémiologie), Inhibiteur p16 de kinase cycline-dépendante (métabolisme), Loi de Poisson, Papillomaviridae (isolement et purification), Papillomavirus humain de type 16 (isolement et purification), Prévalence, Résultat thérapeutique, Sujet âgé, Techniques immunoenzymatiques, Tumeurs du vagin (), Tumeurs du vagin (virologie), Tumeurs du vagin (épidémiologie), États précancéreux (virologie), États précancéreux (épidémiologie), Études rétrospectives, Études transversales.
- MESH :
- analyse : ADN viral.
- isolement et purification : Papillomaviridae, Papillomavirus humain de type 16.
- métabolisme : Inhibiteur p16 de kinase cycline-dépendante.
- virologie : Carcinome épidermoïde, Infections à papillomavirus, Tumeurs du vagin, États précancéreux.
- épidémiologie : Carcinome épidermoïde, Infections à papillomavirus, Tumeurs du vagin, États précancéreux.
- Adulte d'âge moyen, Analyse de régression, Carcinome épidermoïde, Coopération internationale, Femelle, Humains, Infections à papillomavirus, Loi de Poisson, Prévalence, Résultat thérapeutique, Sujet âgé, Techniques immunoenzymatiques, Tumeurs du vagin, Études rétrospectives, Études transversales.
English descriptors
- KwdEn :
- Aged, Carcinoma, Squamous Cell (complications), Carcinoma, Squamous Cell (epidemiology), Carcinoma, Squamous Cell (virology), Cross-Sectional Studies, Cyclin-Dependent Kinase Inhibitor p16 (metabolism), DNA, Viral (analysis), Female, Human papillomavirus 16 (isolation & purification), Humans, Immunoenzyme Techniques, International Cooperation, Middle Aged, Papillomaviridae (isolation & purification), Papillomavirus Infections (complications), Papillomavirus Infections (epidemiology), Papillomavirus Infections (virology), Poisson Distribution, Precancerous Conditions (epidemiology), Precancerous Conditions (virology), Prevalence, Regression Analysis, Retrospective Studies, Treatment Outcome, Vaginal Neoplasms (complications), Vaginal Neoplasms (epidemiology), Vaginal Neoplasms (virology).
- MESH :
- chemical , analysis : DNA, Viral.
- chemical , metabolism : Cyclin-Dependent Kinase Inhibitor p16.
- complications : Carcinoma, Squamous Cell, Papillomavirus Infections, Vaginal Neoplasms.
- epidemiology : Carcinoma, Squamous Cell, Papillomavirus Infections, Precancerous Conditions, Vaginal Neoplasms.
- isolation & purification : Human papillomavirus 16, Papillomaviridae.
- virology : Carcinoma, Squamous Cell, Papillomavirus Infections, Precancerous Conditions, Vaginal Neoplasms.
- Aged, Cross-Sectional Studies, Female, Humans, Immunoenzyme Techniques, International Cooperation, Middle Aged, Poisson Distribution, Prevalence, Regression Analysis, Retrospective Studies, Treatment Outcome.
Abstract
This work describes the human papillomavirus (HPV) prevalence and the HPV type distribution in a large series of vaginal intraepithelial neoplasia (VAIN) grades 2/3 and vaginal cancer worldwide.
DOI: 10.1016/j.ejca.2014.07.018
PubMed: 25155250
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003352
Links to Exploration step
pubmed:25155250Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.</title>
<author><name sortKey="Alemany, L" sort="Alemany, L" uniqKey="Alemany L" first="L" last="Alemany">L. Alemany</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: lalemany@iconcologia.net.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Saunier, M" sort="Saunier, M" uniqKey="Saunier M" first="M" last="Saunier">M. Saunier</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tinoco, L" sort="Tinoco, L" uniqKey="Tinoco L" first="L" last="Tinoco">L. Tinoco</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Oncológico, Quito, Ecuador.</nlm:affiliation>
<country xml:lang="fr">Équateur</country>
<wicri:regionArea>Hospital Oncológico, Quito</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Quir S, B" sort="Quir S, B" uniqKey="Quir S B" first="B" last="Quir S">B. Quir S</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Alvarado Cabrero, I" sort="Alvarado Cabrero, I" uniqKey="Alvarado Cabrero I" first="I" last="Alvarado-Cabrero">I. Alvarado-Cabrero</name>
<affiliation wicri:level="1"><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Mexican Oncology Hospital, IMSS, Mexico, DF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Alejo, M" sort="Alejo, M" uniqKey="Alejo M" first="M" last="Alejo">M. Alejo</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Joura, E A" sort="Joura, E A" uniqKey="Joura E" first="E A" last="Joura">E A Joura</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Maldonado, P" sort="Maldonado, P" uniqKey="Maldonado P" first="P" last="Maldonado">P. Maldonado</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Klaustermeier, J" sort="Klaustermeier, J" uniqKey="Klaustermeier J" first="J" last="Klaustermeier">J. Klaustermeier</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Salmer N, J" sort="Salmer N, J" uniqKey="Salmer N J" first="J" last="Salmer N">J. Salmer N</name>
<affiliation wicri:level="1"><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Mexican Oncology Hospital, IMSS, Mexico, DF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bergeron, C" sort="Bergeron, C" uniqKey="Bergeron C" first="C" last="Bergeron">C. Bergeron</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratoire Cerba, Department de Pathologie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire Cerba, Department de Pathologie, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petry, K U" sort="Petry, K U" uniqKey="Petry K" first="K U" last="Petry">K U Petry</name>
<affiliation wicri:level="1"><nlm:affiliation>Klinikum Wolfsburg, Wolfsburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinikum Wolfsburg, Wolfsburg</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guimera, N" sort="Guimera, N" uniqKey="Guimera N" first="N" last="Guimerà">N. Guimerà</name>
<affiliation wicri:level="1"><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>DDL Diagnostic Laboratory, Rijswijk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clavero, O" sort="Clavero, O" uniqKey="Clavero O" first="O" last="Clavero">O. Clavero</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Murillo, R" sort="Murillo, R" uniqKey="Murillo R" first="R" last="Murillo">R. Murillo</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Cancerología, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Instituto Nacional de Cancerología, Bogotá</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clavel, C" sort="Clavel, C" uniqKey="Clavel C" first="C" last="Clavel">C. Clavel</name>
<affiliation wicri:level="1"><nlm:affiliation>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wain, V" sort="Wain, V" uniqKey="Wain V" first="V" last="Wain">V. Wain</name>
<affiliation wicri:level="1"><nlm:affiliation>WestMead Hospital, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>WestMead Hospital, Sydney</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Geraets, D T" sort="Geraets, D T" uniqKey="Geraets D" first="D T" last="Geraets">D T Geraets</name>
<affiliation wicri:level="1"><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>DDL Diagnostic Laboratory, Rijswijk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jach, R" sort="Jach, R" uniqKey="Jach R" first="R" last="Jach">R. Jach</name>
<affiliation wicri:level="1"><nlm:affiliation>Jagiellonian University Medical College, Krakow, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Jagiellonian University Medical College, Krakow</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cross, P" sort="Cross, P" uniqKey="Cross P" first="P" last="Cross">P. Cross</name>
<affiliation wicri:level="1"><nlm:affiliation>Queen Elizabeth Hospital, Sheriff Hill, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Elizabeth Hospital, Sheriff Hill</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Carrilho, C" sort="Carrilho, C" uniqKey="Carrilho C" first="C" last="Carrilho">C. Carrilho</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo, Mozambique.</nlm:affiliation>
<country xml:lang="fr">Mozambique</country>
<wicri:regionArea>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Molina, C" sort="Molina, C" uniqKey="Molina C" first="C" last="Molina">C. Molina</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Oncología Preventiva, Universidad de Chile, Santiago, Chile.</nlm:affiliation>
<country xml:lang="fr">Chili</country>
<wicri:regionArea>Centro de Oncología Preventiva, Universidad de Chile, Santiago</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shin, H R" sort="Shin, H R" uniqKey="Shin H" first="H R" last="Shin">H R Shin</name>
<affiliation wicri:level="1"><nlm:affiliation>National Cancer Center, Seoul, South Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>National Cancer Center, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mandys, V" sort="Mandys, V" uniqKey="Mandys V" first="V" last="Mandys">V. Mandys</name>
<affiliation wicri:level="1"><nlm:affiliation>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Nowakowski, A M" sort="Nowakowski, A M" uniqKey="Nowakowski A" first="A M" last="Nowakowski">A M Nowakowski</name>
<affiliation wicri:level="1"><nlm:affiliation>Medical University of Lublin, Lublin, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Medical University of Lublin, Lublin</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vidal, A" sort="Vidal, A" uniqKey="Vidal A" first="A" last="Vidal">A. Vidal</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Universitari de Bellvitge, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari de Bellvitge, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lombardi, L" sort="Lombardi, L" uniqKey="Lombardi L" first="L" last="Lombardi">L. Lombardi</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala, Guatemala.</nlm:affiliation>
<country xml:lang="fr">Guatemala</country>
<wicri:regionArea>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kitchener, H" sort="Kitchener, H" uniqKey="Kitchener H" first="H" last="Kitchener">H. Kitchener</name>
<affiliation wicri:level="1"><nlm:affiliation>Manchester Royal Infirmary, Manchester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Manchester Royal Infirmary, Manchester</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sica, A R" sort="Sica, A R" uniqKey="Sica A" first="A R" last="Sica">A R Sica</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo, Uruguay.</nlm:affiliation>
<country xml:lang="fr">Uruguay</country>
<wicri:regionArea>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Maga A Le N, C" sort="Maga A Le N, C" uniqKey="Maga A Le N C" first="C" last="Maga A-Le N">C. Maga A-Le N</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pawlita, M" sort="Pawlita, M" uniqKey="Pawlita M" first="M" last="Pawlita">M. Pawlita</name>
<affiliation wicri:level="1"><nlm:affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>German Cancer Research Center (DKFZ), Heidelberg</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Quint, W" sort="Quint, W" uniqKey="Quint W" first="W" last="Quint">W. Quint</name>
<affiliation wicri:level="1"><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>DDL Diagnostic Laboratory, Rijswijk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bravo, I G" sort="Bravo, I G" uniqKey="Bravo I" first="I G" last="Bravo">I G Bravo</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mu Oz, N" sort="Mu Oz, N" uniqKey="Mu Oz N" first="N" last="Mu Oz">N. Mu Oz</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Institute of Colombia, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Cancer Institute of Colombia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Sanjose, S" sort="De Sanjose, S" uniqKey="De Sanjose S" first="S" last="De Sanjosé">S. De Sanjosé</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bosch, F X" sort="Bosch, F X" uniqKey="Bosch F" first="F X" last="Bosch">F X Bosch</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25155250</idno>
<idno type="pmid">25155250</idno>
<idno type="doi">10.1016/j.ejca.2014.07.018</idno>
<idno type="wicri:Area/PubMed/Corpus">003352</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003352</idno>
<idno type="wicri:Area/PubMed/Curation">003241</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003241</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.</title>
<author><name sortKey="Alemany, L" sort="Alemany, L" uniqKey="Alemany L" first="L" last="Alemany">L. Alemany</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: lalemany@iconcologia.net.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Saunier, M" sort="Saunier, M" uniqKey="Saunier M" first="M" last="Saunier">M. Saunier</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tinoco, L" sort="Tinoco, L" uniqKey="Tinoco L" first="L" last="Tinoco">L. Tinoco</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Oncológico, Quito, Ecuador.</nlm:affiliation>
<country xml:lang="fr">Équateur</country>
<wicri:regionArea>Hospital Oncológico, Quito</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Quir S, B" sort="Quir S, B" uniqKey="Quir S B" first="B" last="Quir S">B. Quir S</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Alvarado Cabrero, I" sort="Alvarado Cabrero, I" uniqKey="Alvarado Cabrero I" first="I" last="Alvarado-Cabrero">I. Alvarado-Cabrero</name>
<affiliation wicri:level="1"><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Mexican Oncology Hospital, IMSS, Mexico, DF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Alejo, M" sort="Alejo, M" uniqKey="Alejo M" first="M" last="Alejo">M. Alejo</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Joura, E A" sort="Joura, E A" uniqKey="Joura E" first="E A" last="Joura">E A Joura</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Maldonado, P" sort="Maldonado, P" uniqKey="Maldonado P" first="P" last="Maldonado">P. Maldonado</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Klaustermeier, J" sort="Klaustermeier, J" uniqKey="Klaustermeier J" first="J" last="Klaustermeier">J. Klaustermeier</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Salmer N, J" sort="Salmer N, J" uniqKey="Salmer N J" first="J" last="Salmer N">J. Salmer N</name>
<affiliation wicri:level="1"><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Mexican Oncology Hospital, IMSS, Mexico, DF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bergeron, C" sort="Bergeron, C" uniqKey="Bergeron C" first="C" last="Bergeron">C. Bergeron</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratoire Cerba, Department de Pathologie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire Cerba, Department de Pathologie, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petry, K U" sort="Petry, K U" uniqKey="Petry K" first="K U" last="Petry">K U Petry</name>
<affiliation wicri:level="1"><nlm:affiliation>Klinikum Wolfsburg, Wolfsburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinikum Wolfsburg, Wolfsburg</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guimera, N" sort="Guimera, N" uniqKey="Guimera N" first="N" last="Guimerà">N. Guimerà</name>
<affiliation wicri:level="1"><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>DDL Diagnostic Laboratory, Rijswijk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clavero, O" sort="Clavero, O" uniqKey="Clavero O" first="O" last="Clavero">O. Clavero</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Murillo, R" sort="Murillo, R" uniqKey="Murillo R" first="R" last="Murillo">R. Murillo</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Cancerología, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Instituto Nacional de Cancerología, Bogotá</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clavel, C" sort="Clavel, C" uniqKey="Clavel C" first="C" last="Clavel">C. Clavel</name>
<affiliation wicri:level="1"><nlm:affiliation>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wain, V" sort="Wain, V" uniqKey="Wain V" first="V" last="Wain">V. Wain</name>
<affiliation wicri:level="1"><nlm:affiliation>WestMead Hospital, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>WestMead Hospital, Sydney</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Geraets, D T" sort="Geraets, D T" uniqKey="Geraets D" first="D T" last="Geraets">D T Geraets</name>
<affiliation wicri:level="1"><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>DDL Diagnostic Laboratory, Rijswijk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jach, R" sort="Jach, R" uniqKey="Jach R" first="R" last="Jach">R. Jach</name>
<affiliation wicri:level="1"><nlm:affiliation>Jagiellonian University Medical College, Krakow, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Jagiellonian University Medical College, Krakow</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cross, P" sort="Cross, P" uniqKey="Cross P" first="P" last="Cross">P. Cross</name>
<affiliation wicri:level="1"><nlm:affiliation>Queen Elizabeth Hospital, Sheriff Hill, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Elizabeth Hospital, Sheriff Hill</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Carrilho, C" sort="Carrilho, C" uniqKey="Carrilho C" first="C" last="Carrilho">C. Carrilho</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo, Mozambique.</nlm:affiliation>
<country xml:lang="fr">Mozambique</country>
<wicri:regionArea>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Molina, C" sort="Molina, C" uniqKey="Molina C" first="C" last="Molina">C. Molina</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Oncología Preventiva, Universidad de Chile, Santiago, Chile.</nlm:affiliation>
<country xml:lang="fr">Chili</country>
<wicri:regionArea>Centro de Oncología Preventiva, Universidad de Chile, Santiago</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shin, H R" sort="Shin, H R" uniqKey="Shin H" first="H R" last="Shin">H R Shin</name>
<affiliation wicri:level="1"><nlm:affiliation>National Cancer Center, Seoul, South Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>National Cancer Center, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mandys, V" sort="Mandys, V" uniqKey="Mandys V" first="V" last="Mandys">V. Mandys</name>
<affiliation wicri:level="1"><nlm:affiliation>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Nowakowski, A M" sort="Nowakowski, A M" uniqKey="Nowakowski A" first="A M" last="Nowakowski">A M Nowakowski</name>
<affiliation wicri:level="1"><nlm:affiliation>Medical University of Lublin, Lublin, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Medical University of Lublin, Lublin</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vidal, A" sort="Vidal, A" uniqKey="Vidal A" first="A" last="Vidal">A. Vidal</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Universitari de Bellvitge, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari de Bellvitge, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lombardi, L" sort="Lombardi, L" uniqKey="Lombardi L" first="L" last="Lombardi">L. Lombardi</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala, Guatemala.</nlm:affiliation>
<country xml:lang="fr">Guatemala</country>
<wicri:regionArea>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kitchener, H" sort="Kitchener, H" uniqKey="Kitchener H" first="H" last="Kitchener">H. Kitchener</name>
<affiliation wicri:level="1"><nlm:affiliation>Manchester Royal Infirmary, Manchester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Manchester Royal Infirmary, Manchester</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sica, A R" sort="Sica, A R" uniqKey="Sica A" first="A R" last="Sica">A R Sica</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo, Uruguay.</nlm:affiliation>
<country xml:lang="fr">Uruguay</country>
<wicri:regionArea>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Maga A Le N, C" sort="Maga A Le N, C" uniqKey="Maga A Le N C" first="C" last="Maga A-Le N">C. Maga A-Le N</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pawlita, M" sort="Pawlita, M" uniqKey="Pawlita M" first="M" last="Pawlita">M. Pawlita</name>
<affiliation wicri:level="1"><nlm:affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>German Cancer Research Center (DKFZ), Heidelberg</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Quint, W" sort="Quint, W" uniqKey="Quint W" first="W" last="Quint">W. Quint</name>
<affiliation wicri:level="1"><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>DDL Diagnostic Laboratory, Rijswijk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bravo, I G" sort="Bravo, I G" uniqKey="Bravo I" first="I G" last="Bravo">I G Bravo</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mu Oz, N" sort="Mu Oz, N" uniqKey="Mu Oz N" first="N" last="Mu Oz">N. Mu Oz</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Institute of Colombia, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Cancer Institute of Colombia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Sanjose, S" sort="De Sanjose, S" uniqKey="De Sanjose S" first="S" last="De Sanjosé">S. De Sanjosé</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bosch, F X" sort="Bosch, F X" uniqKey="Bosch F" first="F X" last="Bosch">F X Bosch</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">European journal of cancer (Oxford, England : 1990)</title>
<idno type="eISSN">1879-0852</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Carcinoma, Squamous Cell (complications)</term>
<term>Carcinoma, Squamous Cell (epidemiology)</term>
<term>Carcinoma, Squamous Cell (virology)</term>
<term>Cross-Sectional Studies</term>
<term>Cyclin-Dependent Kinase Inhibitor p16 (metabolism)</term>
<term>DNA, Viral (analysis)</term>
<term>Female</term>
<term>Human papillomavirus 16 (isolation & purification)</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>International Cooperation</term>
<term>Middle Aged</term>
<term>Papillomaviridae (isolation & purification)</term>
<term>Papillomavirus Infections (complications)</term>
<term>Papillomavirus Infections (epidemiology)</term>
<term>Papillomavirus Infections (virology)</term>
<term>Poisson Distribution</term>
<term>Precancerous Conditions (epidemiology)</term>
<term>Precancerous Conditions (virology)</term>
<term>Prevalence</term>
<term>Regression Analysis</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
<term>Vaginal Neoplasms (complications)</term>
<term>Vaginal Neoplasms (epidemiology)</term>
<term>Vaginal Neoplasms (virology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN viral (analyse)</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de régression</term>
<term>Carcinome épidermoïde ()</term>
<term>Carcinome épidermoïde (virologie)</term>
<term>Carcinome épidermoïde (épidémiologie)</term>
<term>Coopération internationale</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à papillomavirus ()</term>
<term>Infections à papillomavirus (virologie)</term>
<term>Infections à papillomavirus (épidémiologie)</term>
<term>Inhibiteur p16 de kinase cycline-dépendante (métabolisme)</term>
<term>Loi de Poisson</term>
<term>Papillomaviridae (isolement et purification)</term>
<term>Papillomavirus humain de type 16 (isolement et purification)</term>
<term>Prévalence</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Techniques immunoenzymatiques</term>
<term>Tumeurs du vagin ()</term>
<term>Tumeurs du vagin (virologie)</term>
<term>Tumeurs du vagin (épidémiologie)</term>
<term>États précancéreux (virologie)</term>
<term>États précancéreux (épidémiologie)</term>
<term>Études rétrospectives</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>DNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cyclin-Dependent Kinase Inhibitor p16</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>ADN viral</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Papillomavirus Infections</term>
<term>Vaginal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Papillomavirus Infections</term>
<term>Precancerous Conditions</term>
<term>Vaginal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Human papillomavirus 16</term>
<term>Papillomaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Papillomaviridae</term>
<term>Papillomavirus humain de type 16</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Inhibiteur p16 de kinase cycline-dépendante</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Infections à papillomavirus</term>
<term>Tumeurs du vagin</term>
<term>États précancéreux</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Papillomavirus Infections</term>
<term>Precancerous Conditions</term>
<term>Vaginal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Infections à papillomavirus</term>
<term>Tumeurs du vagin</term>
<term>États précancéreux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>International Cooperation</term>
<term>Middle Aged</term>
<term>Poisson Distribution</term>
<term>Prevalence</term>
<term>Regression Analysis</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Analyse de régression</term>
<term>Carcinome épidermoïde</term>
<term>Coopération internationale</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à papillomavirus</term>
<term>Loi de Poisson</term>
<term>Prévalence</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Techniques immunoenzymatiques</term>
<term>Tumeurs du vagin</term>
<term>Études rétrospectives</term>
<term>Études transversales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This work describes the human papillomavirus (HPV) prevalence and the HPV type distribution in a large series of vaginal intraepithelial neoplasia (VAIN) grades 2/3 and vaginal cancer worldwide.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25155250</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>12</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0852</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>50</Volume>
<Issue>16</Issue>
<PubDate><Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>European journal of cancer (Oxford, England : 1990)</Title>
<ISOAbbreviation>Eur. J. Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.</ArticleTitle>
<Pagination><MedlinePgn>2846-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejca.2014.07.018</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0959-8049(14)00870-3</ELocationID>
<Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">This work describes the human papillomavirus (HPV) prevalence and the HPV type distribution in a large series of vaginal intraepithelial neoplasia (VAIN) grades 2/3 and vaginal cancer worldwide.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We analysed 189 VAIN 2/3 and 408 invasive vaginal cancer cases collected from 31 countries from 1986 to 2011. After histopathological evaluation of sectioned formalin-fixed paraffin-embedded samples, HPV DNA detection and typing was performed using the SPF-10/DNA enzyme immunoassay (DEIA)/LiPA25 system (version 1). A subset of 146 vaginal cancers was tested for p16(INK4a) expression, a cellular surrogate marker for HPV transformation. Prevalence ratios were estimated using multivariate Poisson regression with robust variance.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">HPV DNA was detected in 74% (95% confidence interval (CI): 70-78%) of invasive cancers and in 96% (95% CI: 92-98%) of VAIN 2/3. Among cancers, the highest detection rates were observed in warty-basaloid subtype of squamous cell carcinomas, and in younger ages. Concerning the type-specific distribution, HPV16 was the most frequently type detected in both precancerous and cancerous lesions (59%). p16(INK4a) overexpression was found in 87% of HPV DNA positive vaginal cancer cases.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HPV was identified in a large proportion of invasive vaginal cancers and in almost all VAIN 2/3. HPV16 was the most common type detected. A large impact in the reduction of the burden of vaginal neoplastic lesions is expected among vaccinated cohorts.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alemany</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: lalemany@iconcologia.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Saunier</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tinoco</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Hospital Oncológico, Quito, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Quirós</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alvarado-Cabrero</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alejo</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Joura</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
<AffiliationInfo><Affiliation>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Maldonado</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Klaustermeier</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Salmerón</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bergeron</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Laboratoire Cerba, Department de Pathologie, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Petry</LastName>
<ForeName>K U</ForeName>
<Initials>KU</Initials>
<AffiliationInfo><Affiliation>Klinikum Wolfsburg, Wolfsburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guimerà</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clavero</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Murillo</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Instituto Nacional de Cancerología, Bogotá, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clavel</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wain</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>WestMead Hospital, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Geraets</LastName>
<ForeName>D T</ForeName>
<Initials>DT</Initials>
<AffiliationInfo><Affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jach</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Jagiellonian University Medical College, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cross</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Sheriff Hill, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carrilho</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo, Mozambique.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Molina</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Centro de Oncología Preventiva, Universidad de Chile, Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shin</LastName>
<ForeName>H R</ForeName>
<Initials>HR</Initials>
<AffiliationInfo><Affiliation>National Cancer Center, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mandys</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nowakowski</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>Medical University of Lublin, Lublin, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vidal</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Hospital Universitari de Bellvitge, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lombardi</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala, Guatemala.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kitchener</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Manchester Royal Infirmary, Manchester, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sica</LastName>
<ForeName>A R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo><Affiliation>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo, Uruguay.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Magaña-León</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pawlita</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Quint</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bravo</LastName>
<ForeName>I G</ForeName>
<Initials>IG</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Muñoz</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Cancer Institute of Colombia, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>de Sanjosé</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bosch</LastName>
<ForeName>F X</ForeName>
<Initials>FX</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>HPV VVAP study group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>08</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Eur J Cancer</MedlineTA>
<NlmUniqueID>9005373</NlmUniqueID>
<ISSNLinking>0959-8049</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019941">Cyclin-Dependent Kinase Inhibitor p16</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019941" MajorTopicYN="N">Cyclin-Dependent Kinase Inhibitor p16</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D052162" MajorTopicYN="N">Human papillomavirus 16</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D027383" MajorTopicYN="N">Papillomaviridae</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D030361" MajorTopicYN="N">Papillomavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016012" MajorTopicYN="N">Poisson Distribution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014625" MajorTopicYN="N">Vaginal Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Human papillomavirus</Keyword>
<Keyword MajorTopicYN="N">Vaccine</Keyword>
<Keyword MajorTopicYN="N">Vaginal cancer</Keyword>
<Keyword MajorTopicYN="N">Vaginal intraepithelial neoplasia</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>04</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>07</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>07</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>8</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>8</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25155250</ArticleId>
<ArticleId IdType="pii">S0959-8049(14)00870-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.ejca.2014.07.018</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003241 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003241 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25155250 |texte= Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25155250" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |